{"podcast":{"title":"The Vox Markets Podcast","slug":"the-vox-markets-podcast-3914537","podcast_index_feed_id":3914537,"rss_url":"https://audioboom.com/channels/5051662.rss","website_url":"https://audioboom.com/channels/5051662","image_url":"https://audioboom.com/i/40555564.png","author":"jruss88","episode_count":500,"summary":"Vox Markets is revolutionising the way companies engage with all classes of shareholders. Listen here to interviews with company executives and sell-side analysts and fund managers discuss their investment insights.","last_synced_at":"2026-07-24T02:20:32.176878+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537"},"episode":{"title":"2411: Poolbeg Pharma: What US Payers Really Said","slug":"2411-poolbeg-pharma-what-us-payers-really-said","published_at":"2026-06-03T06:17:10+00:00","page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2411-poolbeg-pharma-what-us-payers-really-said","show_page_url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537","url":"https://audioboom.com/posts/8911222","audio_url":"https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8911222.mp3?modified=1780467497&sid=5051662&source=rss","summary":"Watch on YouTube Independent US payer research commissioned by Poolbeg Pharma shows strong commercial backing for POLB 001 — a first-in-class preventative for cancer immunotherapy-induced CRS. Chris from Acumentis Global on what payers said, and what it means for the commercial opportunity ahead.","meta_description":"Watch on YouTube Independent US payer research commissioned by Poolbeg Pharma shows strong commercial backing for POLB 001 — a first-in-class preventative…","key_points":[],"chapters":[],"topics":[],"duration_seconds":881,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2411-poolbeg-pharma-what-us-payers-really-said/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2411-poolbeg-pharma-what-us-payers-really-said.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}